- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Dysregulated Gab1 signalling in triple negative breast cancer ; volume:22 ; number:1 ; day:6 ; month:3 ; year:2024 ; pages:1-19 ; date:12.2024
Cell communication and signaling ; 22, Heft 1 (6.3.2024), 1-19, 12.2024
- Creator
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12964-024-01542-9
- URN
-
urn:nbn:de:101:1-2405100917146.650026400805
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:00 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Bongartz, Hannes
- Mehwald, Nora
- Seiß, Elena A.
- Schumertl, Tim
- Naß, Norbert
- Dittrich, Anna
- SpringerLink (Online service)
Other Objects (12)
Metastatic Triple-Negative Breast Cancer
WNT10B/β‐catenin signalling induces HMGA2 and proliferation in metastatic triple‐negative breast cancer
Comprehensive analysis of the metabolomics and transcriptomics uncovers the dysregulated network and potential biomarkers of Triple Negative Breast Cancer
Naphthoquinone-derived ZSW-4B induces apoptosis in triple-negative breast cancer via AMPK signalling activation
Characterizing triple-negative breast cancer tumors
Triple-Negative Breast Cancer: Multimodality Appearance
Simultaneous inhibition of FAK and ROS1 synergistically repressed triple-negative breast cancer by upregulating p53 signalling
Overcoming acquired resistance to HSP90 inhibition by targeting JAK-STAT signalling in triple-negative breast cancer
Triple negative breast cancer: Pitfalls and progress
Metabolic characterization of triple negative breast cancer
Triple negative breast cancer: A continuing challenge
Immunotherapeutic interventions of Triple Negative Breast Cancer
Metastatic Triple-Negative Breast Cancer
WNT10B/β‐catenin signalling induces HMGA2 and proliferation in metastatic triple‐negative breast cancer
Comprehensive analysis of the metabolomics and transcriptomics uncovers the dysregulated network and potential biomarkers of Triple Negative Breast Cancer
Naphthoquinone-derived ZSW-4B induces apoptosis in triple-negative breast cancer via AMPK signalling activation
Characterizing triple-negative breast cancer tumors
Triple-Negative Breast Cancer: Multimodality Appearance
Simultaneous inhibition of FAK and ROS1 synergistically repressed triple-negative breast cancer by upregulating p53 signalling
Overcoming acquired resistance to HSP90 inhibition by targeting JAK-STAT signalling in triple-negative breast cancer
Triple negative breast cancer: Pitfalls and progress
Metabolic characterization of triple negative breast cancer
Triple negative breast cancer: A continuing challenge
Immunotherapeutic interventions of Triple Negative Breast Cancer
Metastatic Triple-Negative Breast Cancer
WNT10B/β‐catenin signalling induces HMGA2 and proliferation in metastatic triple‐negative breast cancer
Comprehensive analysis of the metabolomics and transcriptomics uncovers the dysregulated network and potential biomarkers of Triple Negative Breast Cancer
Naphthoquinone-derived ZSW-4B induces apoptosis in triple-negative breast cancer via AMPK signalling activation
Characterizing triple-negative breast cancer tumors
Triple-Negative Breast Cancer: Multimodality Appearance
Simultaneous inhibition of FAK and ROS1 synergistically repressed triple-negative breast cancer by upregulating p53 signalling
Overcoming acquired resistance to HSP90 inhibition by targeting JAK-STAT signalling in triple-negative breast cancer
Triple negative breast cancer: Pitfalls and progress
Metabolic characterization of triple negative breast cancer
Triple negative breast cancer: A continuing challenge